PlainRecalls
ModerateClass IIOngoing

FDA Devices recall · Reported May 13, 2026

BioFire Joint Infection (JI) Panel REF: RFIT-ASY-0138, 30 test Kit.

Contamination to in-vitro diagnostic test may result in false positives.

Recall #
Z-2067-2026
Affected scope
106 kits (3,180 test)
Initiated
April 22, 2026
Verify with FDA Devices →
View my saved recalls

BioFire Diagnostics, LLC recalled BioFire Joint Infection (JI) Panel REF: RFIT-ASY-0138, 30 test Kit. - a moderate-severity action.

BioFire Joint Infection (JI) Panel REF: RFIT-ASY-0138, 30 test Kit. was recalled by BioFire Diagnostics, LLC in May 13, 2026. Reason: Contamination to in-vitro diagnostic test may result in false positives.. Check the official notice for the remedy. Verify recall #Z-2067-2026 with the FDA Devices before acting.

The recall

BioFire Diagnostics, LLC issued this moderate-severity FDA Devices recall-Contamination to in-vitro diagnostic test may result in false positives..

Moderate
severity level
Class II
classification
May 13, 2026
reported

Sourced from official FDA Devices enforcement records. Verify recall #Z-2067-2026 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Medical Devices recalls over time

Where this recall sits in its category - 41,021 medical devices recalls on record

01,0002,0003,0004,000 20052008201120142017202020232026 1,947
Severity1906864652High severity (most serious)Moderate severityLow severity
Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

BioFire Joint Infection (JI) Panel REF: RFIT-ASY-0138, 30 test Kit.

Reason for recall

Contamination to in-vitro diagnostic test may result in false positives.

Recall Profile

Structured summary of the FDA Devices recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Moderate (Class II)
Status Ongoing
Recall number Z-2067-2026
Date reported May 13, 2026
Date initiated April 22, 2026
Recalling firm BioFire Diagnostics, LLC
Firm location Salt Lake City, UT
Affected scope 106 kits (3,180 test)
Distribution Worldwide - US Nationwide distribution in the states of TX, NC, UT, MD and the countries of France, Italy, Germany, Spain, Belgium, Switzerland, United Kingdom, Netherlands, Poland, Austria, India, Finland, Czech Republic, Egypt, Lebanon, …

Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (Z-2067-2026) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Devices before acting, recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
BioFire Joint Infection (JI) Panel REF: RFIT-ASY-0138, 30 test Kit.. Recalled by BioFire Diagnostics, LLC. Units affected: 106 kits (3,180 test).
Why was this product recalled?
Contamination to in-vitro diagnostic test may result in false positives.
Which agency issued this recall?
This recall was issued by the FDA Devices on May 13, 2026. Severity: Moderate. Recall number: Z-2067-2026.
Where was the recalled product distributed?
Distribution: Worldwide - US Nationwide distribution in the states of TX, NC, UT, MD and the countries of France, Italy, Germany, Spain, Belgium, Switzerland, United Kingdom, Netherlands, Poland, Austria, India, Finland, Czech Republic, Egypt, Lebanon, Morocco, Slovenia, Romania, Dominican Republic, Serbia..
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Compare this recall with GORE VIABIL Short Wire Biliary Endoprosthesis, Model No. VS… → · All Medical Devices recalls

This recall: FDA Devices, reported May 13, 2026. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026